all 7 news articles
MiddleBrook will use the proceeds to support the manufacture of Moxatag, its once-daily amoxicillin drug, and for working capital and general corporate ...
“The aim of the research was to determine whether home treatment with high-dose oral amoxicillin and inpatient treatment with parenteral ampicillin were ...
By Kendra Marr MiddleBrook Pharmaceuticals said yesterday that federal regulators have approved its once-daily amoxicillin treatment for strep throat, ...
Generic amoxicillin must be taken three times a day, for example, which can be difficult to maintain. Moxatag is more convenient and should improve ...
Just 24 hours after MiddleBrook Pharmaceuticals received approval to market its once-daily amoxicillin treatment for strep throat, the company announced ...
MiddleBrook Pharmaceuticals said that federal regulators have approved its once-daily amoxicillin treatment for strep throat, capping eight years of ups and ...
On Thursday, MiddleBrook executives announced that the Food and Drug Administration had approved Moxatag, its once-daily amoxicillin treatment for strep ...
Instead, the agency's approval of the strep throat drug, called amoxicillin pulsys to be marketed under the brand name Moxatag, sets the company up for a ...
Moxatag is now the first and only once-daily amoxicillin therapy approved for marketing in the US MiddleBrook has agreed with the FDA to continue studying ...